SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yoshihide Ueda, Shinji Uemoto, Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients, Transplantation, 2016, 100, 1, 54

    CrossRef

  2. 2
    Ching-Sheng Hsu, Jia-Horng Kao, Management of hepatitis C patients with decompensated liver disease, Expert Review of Gastroenterology & Hepatology, 2016, 1

    CrossRef

  3. 3
    Varun Saxena, Norah Terrault, Current Management of Hepatitis C Virus, Clinics in Liver Disease, 2015, 19, 4, 669

    CrossRef

  4. 4
    Zoe Mariño, Maria-Carlota Londoño, Xavier Forns, Hepatitis C treatment for patients post liver transplant, Current Opinion in Organ Transplantation, 2015, 20, 3, 251

    CrossRef

  5. You have free access to this content5
    Adam Peyton, Kalyan Ram Bhamidimarri, Hepatitis C treatment in liver transplant setting, Clinical Liver Disease, 2015, 5, 6
  6. 6
    Audrey Coilly, Bruno Roche, Jean-Charles Duclos-Vallée, Didier Samuel, Management of post transplant hepatitis C in the direct antiviral agents era, Hepatology International, 2015, 9, 2, 192

    CrossRef

  7. 7
    Surakit Pungpapong, Bashar Aqel, Michael Leise, K. Tuesday Werner, Jennifer L. Murphy, Tanisha M. Henry, Kristen Ryland, Amy E. Chervenak, Kymberly D. Watt, Hugo E. Vargas, Andrew P. Keaveny, Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant, Hepatology, 2015, 61, 6
  8. 8
    Tomomi Kogiso, Katsutoshi Tokushige, Etsuko Hashimoto, Makiko Taniai, Akiko Omori, Yoshihito Kotera, Hiroto Egawa, Masakazu Yamamoto, Keiko Shiratori, Mycophenolate mofetil may induce prolonged severe anemia during pegylated-interferon/ribavirin/simeprevir therapy in liver transplant recipients, Clinical Journal of Gastroenterology, 2015, 8, 3, 156

    CrossRef

  9. You have free access to this content9
    Audrey Coilly, Bruno Roche, Jean-Charles Duclos-Vallée, Didier Samuel, Optimal therapy in hepatitis C virus liver transplant patients with direct acting antivirals, Liver International, 2015, 35,
  10. 10
    P.E. Ruiter, P.P.C. Boor, J. Jonge, H.J. Metselaar, H.W. Tilanus, J.N. Ijzermans, J. Kwekkeboom, L.J.W. Laan, Prednisolone does not affect direct-acting antivirals against hepatitis C, but inhibits interferon-alpha production by plasmacytoid dendritic cells, Transplant Infectious Disease, 2015, 17, 5
  11. 11
    Hyeyoung Kim, Kwang-Woong Lee, Nam-Joon Yi, Hae Won Lee, YoungRok Choi, Suk-Won Suh, Jaehong Jeong, Kyung-Suk Suh, Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation, Journal of Korean Medical Science, 2015, 30, 11, 1577

    CrossRef

  12. 12
    Michael Charlton, Edward Gane, Michael P. Manns, Robert S. Brown, Michael P. Curry, Paul Y. Kwo, Robert J. Fontana, Richard Gilroy, Lewis Teperman, Andrew J. Muir, John G. McHutchison, William T. Symonds, Diana Brainard, Brian Kirby, Hadas Dvory-Sobol, Jill Denning, Sarah Arterburn, Didier Samuel, Xavier Forns, Norah A. Terrault, Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation, Gastroenterology, 2015, 148, 1, 108

    CrossRef

  13. 13
    Saro Khemichian, Brian Lee, Jeffrey Kahn, Mazen Noureddin, Brian Kim, Tammy Harper, Yvonne Esmailian, Tse-Ling Fong, Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation, Transplantation Direct, 2015, 1, 6, 1

    CrossRef

  14. 14
    K. Herzer, G. Gerken, Therapie der Hepatitis C bei Patienten mit Zirrhose sowie vor und nach Lebertransplantation, Der Gastroenterologe, 2015, 10, 4, 297

    CrossRef

  15. 15
    Jennifer C. Price, Norah A. Terrault, Treatment of hepatitis C in liver transplant patients: Interferon out, direct antiviral combos in, Liver Transplantation, 2015, 21, 4
  16. 16
    Marina Berenguer, John R. Lake, Transplantation of the Liver, 2015,

    CrossRef

  17. 17
    James R. Burton, Jacqueline G. O’Leary, Elizabeth C. Verna, Varun Saxena, Jennifer L. Dodge, Richard T. Stravitz, Joshua Levitsky, James F. Trotter, Gregory T. Everson, Robert S. Brown, Norah A. Terrault, A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy, Journal of Hepatology, 2014, 61, 3, 508

    CrossRef

  18. 18
    Jacqueline G. O'Leary, Hugo Kaneku, Linda Jennings, Brian M. Susskind, Paul I. Terasaki, Göran B. Klintmalm, Donor-specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus–infected patients, Liver Transplantation, 2014, 20, 6
  19. 19
    Sabela Lens, Zoe Mariño, Xavier Forns, Efficacy of new direct acting antivirals in transplant recipients and patients with advanced disease, Digestive and Liver Disease, 2014, 46, S197

    CrossRef

  20. 20
    Sobia Kanwal, Tariq Mahmood, Hepatitis C virus resistance to interferon therapy: an alarming situation, Open Life Sciences, 2014, 9, 12

    CrossRef

  21. 21
    Elizabeth C. Verna, Hepatitis Viruses and Liver Transplantation, Clinics in Liver Disease, 2014, 18, 3, 575

    CrossRef

  22. You have free access to this content22
    Audrey Coilly, Bruno Roche, Jean-Charles Duclos-Vallée, Didier Samuel, Management of HCV transplant patients with triple therapy, Liver International, 2014, 34,
  23. 23
    Bruno Roche, Audrey Coilly, Jean-Charles Duclos-Vallée, Didier Samuel, Optimal Management of HCV Transplant Patients, Current Hepatology Reports, 2014, 13, 4, 304

    CrossRef

  24. 24
    Sabela Lens, Ignacio Alfaro, Perspectivas futuras del tratamiento de la hepatitis C, ¿sin interferón y sin ribavirina?, Gastroenterología y Hepatología, 2014, 37, 5, 311

    CrossRef

  25. 25
    Audrey Coilly, Bruno Roche, Jérôme Dumortier, Vincent Leroy, Danielle Botta-Fridlund, Sylvie Radenne, Georges-Philippe Pageaux, Si-Nafaa Si-Ahmed, Olivier Guillaud, Teresa Maria Antonini, Stéphanie Haïm-Boukobza, Anne-Marie Roque-Afonso, Didier Samuel, Jean-Charles Duclos-Vallée, Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience, Journal of Hepatology, 2014, 60, 1, 78

    CrossRef

  26. 26
    Martina Gambato, Sabela Lens, Miquel Navasa, Xavier Forns, Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation, Journal of Hepatology, 2014, 61, 1, S120

    CrossRef

  27. You have free access to this content27
    Audrey Coilly, Bruno Roche, Didier Samuel, Current management and perspectives for HCV recurrence after liver transplantation, Liver International, 2013, 33,
  28. 28
    Marina Berenguer, Bruno Roche, Victoria Aguilera, Jean-Charles Duclos-Vallée, Laia Navarro, Angel Rubín, Jose-Antonio Pons, Manuel de la Mata, Martín Prieto, Didier Samuel, Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: Role of an aggressive approach, Liver Transplantation, 2013, 19, 1
  29. 29
    Susanne Beckebaum, Iyad Kabar, Vito R. Cicinnati, Hepatitis B and C in liver transplantation: new strategies to combat the enemies, Reviews in Medical Virology, 2013, 23, 3
  30. You have free access to this content30
    Elizabeth C. Verna, Hepatitis C virus: Management of recurrent disease, Clinical Liver Disease, 2013, 2, 4
  31. 31
    Toru Ikegami, Ken Shirabe, Tomoharu Yoshizumi, Norihiro Furusyo, Kazuhiro Kotoh, Masaki Kato, Shinji Shimoda, Yuji Soejima, Takashi Motomura, Takasuke Fukuhara, Yoshihiko Maehara, Impact of Conversion From Pegylated Interferon-α2b to Interferon-α2a for Treating Recurrent Hepatitis C After Liver Transplantation, Transplantation Journal, 2013, 95, 6, e38

    CrossRef

  32. 32
    Manuel Romero-Gómez, Marina Berenguer, Esther Molina, José Luis Calleja, Management of anemia induced by triple therapy in patients with chronic hepatitis C: Challenges, opportunities and recommendations, Journal of Hepatology, 2013, 59, 6, 1323

    CrossRef

  33. 33
    Sung Won Lee, Si Hyun Bae, Management of Hepatitis C Viral Infection Pre- and Post-liver Transplantation, The Journal of the Korean Society for Transplantation, 2013, 27, 1, 1

    CrossRef

  34. 34
    James R. Burton, Gregory T. Everson, Management of the Transplant Recipient with Chronic Hepatitis C, Clinics in Liver Disease, 2013, 17, 1, 73

    CrossRef

  35. 35
    Surakit Pungpapong, Bashar A. Aqel, Ludi Koning, Jennifer L. Murphy, Tanisha M. Henry, Kristen L. Ryland, Maria L. Yataco, Raj Satyanarayana, Barry G. Rosser, Hugo E. Vargas, Michael R. Charlton, Andrew P. Keaveny, Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation, Liver Transplantation, 2013, 19, 7
  36. 36
    Shih-Hsien Hsu, Ming-Lun Yeh, Shen-Nien Wang, New Insights in Recurrent HCV Infection after Liver Transplantation, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  37. 37
    Jennifer C. Price, Prevention and Treatment of Recurrent Hepatitis C after Liver Transplantation, Current Hepatitis Reports, 2013, 12, 4, 227

    CrossRef

  38. 38
    Marina Berenguer, Detlef Schuppan, Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatment, Journal of Hepatology, 2013, 58, 5, 1028

    CrossRef

  39. You have free access to this content39
    D. Joshi, I. Carey, K. Agarwal, Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients, Alimentary Pharmacology & Therapeutics, 2013, 37, 7
  40. 40
    Roberto Galuppo, Angie McCall, Roberto Gedaly, The Role of Bridging Therapy in Hepatocellular Carcinoma, International Journal of Hepatology, 2013, 2013, 1

    CrossRef

  41. 41
    Kosh Agarwal, Ashley Barnabas, Treatment of chronic hepatitis C virus infection after liver transplantation, Digestive and Liver Disease, 2013, 45, S349

    CrossRef

  42. 42
    J. Levitsky, K. Doucette, Viral Hepatitis in Solid Organ Transplantation, American Journal of Transplantation, 2013, 13, s4
  43. 43
    Luca S. Belli, Riccardo Volpes, Ivo Graziadei, Stefano Fagiuoli, Peter Starkel, Patrizia Burra, Alberto B. Alberti, Bruno Gridelli, Wolfgang Vogel, Luisa Pasulo, Eleonora De Martin, Maria Guido, Luciano De Carlis, Jan Lerut, Umberto Cillo, Andrew K. Burroughs, Giovambattista Pinzello, Antiviral therapy and fibrosis progression in patients with mild–moderate hepatitis C recurrence after liver transplantation. A randomized controlled study, Digestive and Liver Disease, 2012, 44, 7, 603

    CrossRef

  44. 44
    Marina Berenguer, Victoria Aguilera, Angel Rubín, Cecilia Ortíz, Martina Jimenez, Martín Prieto, Comparison of two non-contemporaneous HCV-liver transplant cohorts: Strategies to improve the efficacy of antiviral therapy, Journal of Hepatology, 2012, 56, 6, 1310

    CrossRef

  45. You have free access to this content45
    Elizabeth C. Verna, Robert S. Brown, Hepatitis C viral infection after liver transplantation, Clinical Liver Disease, 2012, 1, 3
  46. 46
    Tommaso Maria Manzia, Roberta Angelico, Luca Toti, Quirino Lai, Paolo Ciano, Mario Angelico, Giuseppe Tisone, Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation, Expert Review of Clinical Immunology, 2012, 8, 7, 635

    CrossRef

  47. 47
    Varun Saxena, Norah Terrault, Hepatitis C virus treatment and liver transplantation in the era of new antiviral therapies, Current Opinion in Organ Transplantation, 2012, 17, 3, 216

    CrossRef

  48. 48
    Bruno Roche, Didier Samuel, Hepatitis C virus treatment pre- and post-liver transplantation, Liver International, 2012, 32,
  49. 49
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Liver Transplantation and Hepatitis C, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  50. 50
    Norah Terrault, Liver transplantation in the setting of chronic HCV, Best Practice & Research Clinical Gastroenterology, 2012, 26, 4, 531

    CrossRef

  51. 51
    Manav Wadhawan, Sunil Taneja, Rajeev Shandil, Neerav Goyal, Subash Gupta, Ajay Kumar, Management of chronic hepatitis C before and after liver transplant, Apollo Medicine, 2012, 9, 1, 24

    CrossRef

  52. 52
    Josh Levitsky, Maria Isabel Fiel, John P. Norvell, Edward Wang, Kymberly D. Watt, Michael P. Curry, Sumeet Tewani, Timothy M. McCashland, Maarouf A. Hoteit, Abraham Shaked, Samuel Saab, Amanda C. Chi, Amy Tien, Thomas D. Schiano, Risk for Immune-Mediated Graft Dysfunction in Liver Transplant Recipients With Recurrent HCV Infection Treated With Pegylated Interferon, Gastroenterology, 2012, 142, 5, 1132

    CrossRef

  53. 53
    Marina Berenguer, Ramón Charco, Juan Manuel Pascasio, Jose Ignacio Herrero, Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation, Liver International, 2012, 32, 5
  54. 54
    Michela Giusto, Maria Rodriguez, Laia Navarro, Angel Rubin, Victoria Aguilera, Fernando San-Juan, Cecilia Ortiz, Rafael López-Andujar, Martín Prieto, Marina Berenguer, Anemia is not predictive of sustained virological response in liver transplant recipients with hepatitis C virus who are treated with pegylated interferon and ribavirin, Liver Transplantation, 2011, 17, 11
  55. 55
    Süleyman Yedibela, Resit Demir, Nathaniel Melling, Ünal Aydin, Detlef Schuppan, Volker Müller, Werner Hohenberger, Frank Schönleben, Antiviral re-treatment of IFN-Ribavirin non-responders for recurrent post-transplantation hepatitis C, Clinical Transplantation, 2011, 25, 1
  56. 56
    III Consensus Meeting of the Spanish Society of Liver Transplantation. Hepatitis C, Living-donor Liver Transplantation, Quality of Liver Grafts and of Liver Transplantation Programs, Cirugía Española (English Edition), 2011, 89, 8, 487

    CrossRef

  57. 57
    III Reunión de consenso de la Sociedad Española de Trasplante Hepático (SETH). Hepatitis C, trasplante hepático de donante vivo, calidad de los injertos hepáticos y calidad de los programas de trasplante hepático, Cirugía Española, 2011, 89, 8, 487

    CrossRef

  58. 58
    J. Ignacio Herrero, III Reunión de consenso de la Sociedad Española de Trasplante Hepático (SETH). Hepatitis C, trasplante hepático de donante vivo, calidad de los injertos hepáticos y calidad de los programas de trasplante hepático, Gastroenterología y Hepatología, 2011, 34, 9, 641

    CrossRef

  59. 59
    Nazia Selzner, Maha Guindi, Eberhard L. Renner, Marina Berenguer, Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients, Journal of Hepatology, 2011, 55, 1, 207

    CrossRef

  60. 60
    Bruno Roche, Didier Samuel, Is early antiviral therapy for recurrent hepatitis C after liver transplantation superior to later treatment? The answer is no, Liver Transplantation, 2011, 17, 5
  61. 61
    A. Rubín, V. Aguilera, M. Berenguer, Liver transplantation and hepatitis C, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 12, 805

    CrossRef

  62. 62
    F.R. Ponziani, A. Gasbarrini, M. Pompili, P. Burra, S. Fagiuoli, Management of Hepatitis C Virus Infection Recurrence After Liver Transplantation: An Overview, Transplantation Proceedings, 2011, 43, 1, 291

    CrossRef

  63. 63
    A. Sidney Barritt, Jama M. Darling, Paul H. Hayashi, New and Evolving Management Paradigms for Hepatitis C after Liver Transplantation, Current Hepatitis Reports, 2011, 10, 3, 179

    CrossRef

  64. 64
    Natalie Bzowej, David R. Nelson, Norah A. Terrault, Gregory T. Everson, Lichen L. Teng, Avinash Prabhakar, Michael R. Charlton, PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus, Liver Transplantation, 2011, 17, 5
  65. 65
    Michael Charlton, Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents — A potentially lethal cocktail, Hepatology, 2011, 54, 1
  66. 66
    John O'Grady, The immunoreactive patient: Rejection and autoimmune disease, Liver Transplantation, 2011, 17, S3
  67. 67
    Marina Berenguer, Treatment of hepatitis C in the post-transplant setting, Digestive and Liver Disease Supplements, 2011, 5, 1, 26

    CrossRef

  68. 68
    Jan Peveling-Oberhag, Stefan Zeuzem, Wolf Peter Hofmann, Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation, Medical Microbiology and Immunology, 2010, 199, 1, 1

    CrossRef

  69. 69
    Yasuhiko Sugawara, Sumihito Tamura, Norihiro Kokudo, Antiviral Treatment for Hepatitis C Virus Infection after Liver Transplantation, Hepatitis Research and Treatment, 2010, 2010, 1

    CrossRef

  70. 70
    Hokkaido Liver Transplantation Stud, Masahiko Taniguchi, Hiroyuki Furukawa, Tsuyoshi Shimamura, Tomomi Suzuki, Kenichiro Yamashita, Satoru Todo, Deceased donor liver transplantation, Kanzo, 2010, 51, 4, 143

    CrossRef

  71. You have free access to this content71
    Bruno Roche, Didier Samuel, Hepatitis C virus: Up to the minute, Liver Transplantation, 2010, 16, S2
  72. 72
    Ayse Aytaman, Marina Kaufman, Norah A Terrault, Management of posttransplant hepatitis C infection, Current Opinion in Organ Transplantation, 2010, 15, 3, 301

    CrossRef

  73. 73
    Kimberly A. Brown, Natural History and Treatment of Hepatitis C in Liver Transplant Recipients, Current Hepatitis Reports, 2010, 9, 1, 30

    CrossRef

  74. 74
    Sumihito Tamura, Yasuhiko Sugawara, Noriyo Yamashiki, Junichi Kaneko, Norihiro Kokudo, Masatoshi Makuuchi, Pre-emptive antiviral therapy in living donor liver transplantation for hepatitis C: observation based on a single-center experience, Transplant International, 2010, 23, 6
  75. 75
    Akiyoshi Kinoshita, Munenori Itagaki, Yoshihiko Aoki, Hiroshi Matsudaira, Haruya Ishiguro, Toshiki Nikami, Shinichiro Uetake, Shingo Takikawa, Yasuyuki Searashi, Kazuhiko Koike, Atsushi Hokari, Tomohisa Ishikawa, Hiroki Takahashi, Mikio Zeniya, Hisao Tajiri, Makoto Odaka, A case of recurrent hepatitis C after liver transplantation associated with pulmonary tuberculosis and mediastinal tuberculous lymphadenitis, Kanzo, 2009, 50, 9, 520

    CrossRef

  76. 76
    K. Watt, B. Veldt, M. Charlton, A Practical Guide to the Management of HCV Infection Following Liver Transplantation, American Journal of Transplantation, 2009, 9, 8
  77. 77
    Thomas Walter, Jean-Yves Scoazec, Olivier Guillaud, Valérie Hervieu, Philippe Chevallier, Olivier Boillot, Jérôme Dumortier, Long-term antiviral therapy for recurrent hepatitis C after liver transplantation in nonresponders: Biochemical, virological, and histological impact, Liver Transplantation, 2009, 15, 1
  78. 78
    Natasha Walzer, Steven L Flamm, Pegylated IFN-α and ribavirin: emerging data in the treatment of special populations, Expert Review of Clinical Pharmacology, 2009, 2, 1, 67

    CrossRef

  79. 79
    J. Levitsky, K. Doucette, Viral Hepatitis in Solid Organ Transplant Recipients, American Journal of Transplantation, 2009, 9,
  80. 80
    M. Berenguer, A. Palau, V. Aguilera, J.-M. Rayón, F. S. Juan, M. Prieto, Clinical Benefits of Antiviral Therapy in Patients with Recurrent Hepatitis C Following Liver Transplantation, American Journal of Transplantation, 2008, 8, 3
  81. 81
    Elizabeth C. Verna, Robert S. Brown, Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted, Clinics in Liver Disease, 2008, 12, 3, 637

    CrossRef

  82. 82
    Norah A. Terrault, Hepatitis C therapy before and after liver transplantation, Liver Transplantation, 2008, 14, S2
  83. 83
    Bruno Roche, Mylene Sebagh, Maria Laura Canfora, Teresa Antonini, Anne-Marie Roque-Afonso, Valerie Delvart, Faouzi Saliba, Jean-Charles Duclos-Vallee, Denis Castaing, Didier Samuel, Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis, Liver Transplantation, 2008, 14, 12
  84. 84
    Daniel S Pratt, Liver disorders, Current Opinion in Gastroenterology, 2008, 24, 3, 265

    CrossRef

  85. 85
    Adnan Said, Michael R Lucey, Liver transplantation: an update 2008, Current Opinion in Gastroenterology, 2008, 24, 3, 339

    CrossRef

  86. 86
    E. Xirouchakis, C. Triantos, P. Manousou, A. Sigalas, V. Calvaruso, A. Corbani, G. Leandro, D. Patch, A. Burroughs, Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies, Journal of Viral Hepatitis, 2008, 15, 10
  87. You have free access to this content87
    Sumihito Tamura, Yasuhiko Sugawara, Treatment strategy for hepatitis C after liver transplantation, Journal of Hepato-Biliary-Pancreatic Surgery, 2008, 15, 2
  88. 88
    Massimiliano Fontana, Donatella Ciuffreda, Darius Moradpour, Manuel Pascual, Combined Antiviral Therapy for Recurrent Hepatitis C Virus After Liver Transplantation, Transplantation, 2007, 83, 4, 525

    CrossRef

  89. 89
    Adnan Said, Michael Einstein, Michael R Lucey, Liver transplantation: an update 2007, Current Opinion in Gastroenterology, 2007, 23, 3, 292

    CrossRef

  90. 90
    Giuseppe Tisone, Giuseppe Orlando, Mario Angelico, Operational tolerance in clinical liver transplantation: Emerging developments, Transplant Immunology, 2007, 17, 2, 108

    CrossRef

  91. 91
    V. R. CICINNATI, S. IACOB, C. G. KLEIN, H. A. BABA, G. C. SOTIROPOULOS, P. HILGARD, Y. ERIM, C. E. BROELSCH, G. GERKEN, S. BECKEBAUM, Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation, Alimentary Pharmacology & Therapeutics, 2007, 26, 2
  92. 92
    Pratima Sharma, Jorge A. Marrero, Robert J. Fontana, Joel K. Greenson, Hari Conjeevaram, Grace L. Su, Frederick Askari, Patricia Sullivan, Anna S. Lok, Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence, Liver Transplantation, 2007, 13, 8
  93. 93
    Elizabeth C. Verna, Robert S. Brown, Hepatitis C Virus and Liver Transplantation, Clinics in Liver Disease, 2006, 10, 4, 919

    CrossRef

  94. 94
    Kimberly A Brown, Mary Ann Huang, Marwan Kazimi, Dilip Moonka, Liver Transplantation,
  95. 95
    Norah Terrault, Liver Transplantation in Patients with Hepatitis B, C or HIV Infection,
  96. 96
    Kiran Bambha, Norah A. Terrault, Long-Term Management of Recurrent Primary Liver Disease,